These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16330454)

  • 21. Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods.
    Malek E; Sendilnathan A; Yellu M; Petersen A; Fernandez-Ulloa M; Driscoll JJ
    Blood Cancer J; 2015 Jul; 5(7):e326. PubMed ID: 26207787
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-Hit Lymphoma.
    Goyal G; Caponetti GC; Silberstein PT
    J Clin Exp Hematop; 2015; 55(1):51-3. PubMed ID: 26106008
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    Shah GL; Moskowitz CH
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1215-1228. PubMed ID: 27888876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
    Kurtz DM; Scherer F; Jin MC; Soo J; Craig AFM; Esfahani MS; Chabon JJ; Stehr H; Liu CL; Tibshirani R; Maeda LS; Gupta NK; Khodadoust MS; Advani RH; Levy R; Newman AM; Dührsen U; Hüttmann A; Meignan M; Casasnovas RO; Westin JR; Roschewski M; Wilson WH; Gaidano G; Rossi D; Diehn M; Alizadeh AA
    J Clin Oncol; 2018 Oct; 36(28):2845-2853. PubMed ID: 30125215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome.
    Richter J; Hüttmann A; Rekowski J; Schmitz C; Gärtner S; Rosenwald A; Hansmann ML; Hartmann S; Möller P; Wacker HH; Feller A; Thorns C; Müller S; Dührsen U; Klapper W
    Blood Cancer J; 2019 Aug; 9(9):67. PubMed ID: 31427567
    [No Abstract]   [Full Text] [Related]  

  • 26. An unusual presentation of lymphoma in a patient with rheumatoid arthritis in remission.
    Wig S; Haworth J
    Rheumatology (Oxford); 2015 Oct; 54(10):1875. PubMed ID: 26248810
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to Wu et al.
    Platt MY; DeLelys ME; Preffer FI; Sohani AR
    Cytometry B Clin Cytom; 2013; 84(6):399. PubMed ID: 24038942
    [No Abstract]   [Full Text] [Related]  

  • 28. Surveillance in Patients With Diffuse Large B Cell Lymphoma.
    Kallam A; Adusumalli J; Armitage JO
    Mayo Clin Proc; 2020 Jan; 95(1):157-163. PubMed ID: 31902411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiologic case study. Lymphoma of the distal femur.
    Freire M; Simonelli PS
    Orthopedics; 2010 Jan; 33(1):54. PubMed ID: 20052946
    [No Abstract]   [Full Text] [Related]  

  • 30. Interim positron emission tomography in limited-stage diffuse large B cell lymphoma: A modern will-o'-the-wisp?
    Pathak N; Pushpam D; Bakhshi S
    Natl Med J India; 2021; 34(1):37-39. PubMed ID: 34397004
    [No Abstract]   [Full Text] [Related]  

  • 31. A 21-Year-Old With Right Lower Extremity Edema.
    Guzzardo G; Gowans LK
    Clin Pediatr (Phila); 2021 Feb; 60(2):99. PubMed ID: 32856469
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.
    Meignan M; Itti E; Bardet S; Lumbroso J; Edeline V; Olivier P; Borght TV; Reman O; Karcher G; Mundler O; Mounier N; Ricci R; Federico M; Raemaekers J; André M
    J Clin Oncol; 2009 Jun; 27(16):2739-41. PubMed ID: 19398565
    [No Abstract]   [Full Text] [Related]  

  • 33. Resected Diffuse Large B Cell Lymphoma: Does Extirpation Mean No Irradiation in the PET-Response Based Milieu?
    McMullen KP; Sawyer J
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):716-717. PubMed ID: 38851267
    [No Abstract]   [Full Text] [Related]  

  • 34. Hot lungs, bitter cherry: intravascular lymphoma.
    Génin V; Enfrein A; Lecouffe-Desprets M; Gallas P; Bossard C; Moreau A; Ansquer C; Hamidou M; Agard C; Néel A
    QJM; 2018 Jan; 111(1):53-54. PubMed ID: 29186525
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosis in diffuse large B-cell lymphoma: the picture continues to come into focus.
    Muffly LS; Smith SM
    Cancer; 2013 Mar; 119(6):1129-31. PubMed ID: 23212789
    [No Abstract]   [Full Text] [Related]  

  • 36. Suboptimal use of imaging in the new (National Comprehensive Cancer Network) International Prognostic Index for diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):806-7. PubMed ID: 24442597
    [No Abstract]   [Full Text] [Related]  

  • 37. Reporting interim positron emission tomography in diffuse large B-cell lymphoma: the Zeno's paradox.
    Meignan M
    Leuk Lymphoma; 2014 Apr; 55(4):730-2. PubMed ID: 24093835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Picture of the month: talc in pleura].
    Frederiksen H; Ormstrup T; Østergaard B; Hartling O
    Ugeskr Laeger; 2008 Aug; 170(33):2459. PubMed ID: 18761831
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
    Hatzl S; Kalmar P; Posch F; Riedl JM; Beham-Schmid C; Prochazka K; Greinix H; Schwarz T; Gstettner C; Neumeister P; Schulz E
    Hemasphere; 2021 Aug; 5(8):e621. PubMed ID: 34263145
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma.
    Yang DH; Jung SH; Ahn JS; Kim YK; Min JJ; Bom HS; Lee JJ; Kim HJ
    Chonnam Med J; 2015 Dec; 51(3):109-14. PubMed ID: 26730361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.